Perrigo's

Perrigo's (PRGO) fiscal Q2 earnings rose 13% to $1.36 per share, beating analyst projections by 5 cents as revenue gains from acquisitions and products for the consumer health care segment offset higher expenses. The generic-drug maker's sales for the quarter ended Dec. 29 rose 5% to $883 mil, edging views for $881 mil. Shares rose 4.8% to 105.28.